|
UBE4B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.77099999999886E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.755800E-02 |
| Normal-vs-Stage2 |
1.140830E-03 |
| Normal-vs-Stage3 |
8.92580000022569E-07 |
| Normal-vs-Stage4 |
1.38740000044102E-07 |
| Stage1-vs-Stage2 |
2.457700E-02 |
| Stage1-vs-Stage3 |
2.242100E-04 |
| Stage1-vs-Stage4 |
3.64540000000746E-05 |
| Stage2-vs-Stage3 |
6.484800E-01 |
| Stage2-vs-Stage4 |
2.369800E-01 |
| Stage3-vs-Stage4 |
3.464600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.99559999999721E-05 |
| Normal-vs-AfricanAmerican |
2.620900E-03 |
| Normal-vs-Asian |
7.022200E-01 |
| Caucasian-vs-AfricanAmerican |
6.609800E-01 |
| Caucasian-vs-Asian |
4.136600E-01 |
| AfricanAmerican-vs-Asian |
2.981400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.17449999999619E-05 |
| Normal-vs-Female |
4.260600E-03 |
| Male-vs-Female |
1.229380E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.088200E-02 |
| Normal-vs-Age(41-60Yrs) |
7.063400E-03 |
| Normal-vs-Age(61-80Yrs) |
3.95180000000162E-05 |
| Normal-vs-Age(81-100Yrs) |
3.206400E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.096200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.415800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.607380E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.202020E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.035100E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.320200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.074100E-02 |
| Normal-vs-Grade 2 |
2.312400E-01 |
| Normal-vs-Grade 3 |
1.61580000046513E-07 |
| Normal-vs-Grade 4 |
3.21699999972225E-10 |
| Grade 1-vs-Grade 2 |
5.664200E-02 |
| Grade 1-vs-Grade 3 |
3.561800E-04 |
| Grade 1-vs-Grade 4 |
9.9775999995444E-07 |
| Grade 2-vs-Grade 3 |
1.92040000002169E-06 |
| Grade 2-vs-Grade 4 |
2.91010004982439E-09 |
| Grade 3-vs-Grade 4 |
3.826300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.230200E-01 |
| Normal-vs-ccB subtype |
4.20289999469858E-08 |
| ccA subtype-vs-ccB subtype |
8.28159996135724E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.17379999999379E-05 |
| Normal-vs-N1 |
7.190000E-04 |
| N0-vs-N1 |
3.032600E-01 |
|
|
